Drug intelligence / Profile preview

ONF

Development stage: Preclinical
Lead developer: National Natural Science Foundation of China

Overview

ONF is an investigational drug being researched as a synergist to the oncolytic virus ON-01 for the treatment of high-grade gliomas. Its specific mechanism of action, beyond enhancing the effect of ON-01, is not detailed in the available information. It is being developed by a collaboration of Chinese research institutions.

Beyond the preview

Go deeper on ONF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ONF.

Explore the full profile